P/E ratio for Jaguar Health (JAGX)
P/E ratio as of April 2025 (TTM): -0.3272
According to Jaguar Health's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.327243. At the end of 2022 the company had a P/E ratio of -8.83.
P/E ratio history for Jaguar Health from 2015 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -8.83 | -83.92% |
| 2021 | -54.9 | 46.63% |
| 2020 | -37.4 | 2587.72% |
| 2019 | -1.39 | -83.62% |
| 2018 | -8.50 | -48.81% |
| 2017 | -16.6 | -49.79% |
| 2016 | -33.1 | -49.6% |
| 2015 | -65.6 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 | 70.4 | -21,626.08% | 🇮🇱 Israel |
 | N/A | N/A | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.